Dr Clair Brooks of Copley Scientific looks at some of the in-use issues and patient effects that good design of devices for orally inhaled drug products can address within the context of regulatory requirements for the demonstration of robustness.
Developing Robust Orally Inhaled Products to Achieve Better Patient Outcomes
Download PDF

Training & Support
Find out more about the broad range of training opportunities and comprehensive support we offer customers